Problem-Solving Therapy for People With Major Depression and Chronic Obstructive Pulmonary Disease

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

101 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-02-29

Study Completion Date

2015-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will evaluate the effectiveness of problem-solving therapy combined with treatment adherence procedures in treating older people with major depression and chronic obstructive pulmonary disease.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Cognitive-Behavioral Intervention for Depression and Anxiety in COPD

NCT00105911

Depressive Disorders Anxiety Disorders Pulmonary Disease, Chronic Obstructive

COMPLETED NA

Effectiveness of Case Management Versus Case Management Plus Problem-solving Therapy to Treat Depression in Low-income Elders

NCT00540865

Depression

COMPLETED NA

Combined Illness Management and Psychotherapy in Treating Depressed Elders

NCT01337726

Depression Heart Failure Chronic Obstructive Pulmonary Disease

COMPLETED NA

Psychotherapy for Late Life Depression

NCT01698255

Depression

COMPLETED NA

Retaining Cognition While Avoiding Late-Life Depression

NCT01886586

Mild Cognitive Impairment

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Depression is a serious illness that affects a person's mood, thoughts, and physical well-being. Common symptoms of depression include persistent feelings of anxiety, guilt, or hopelessness; irregular sleep and appetite patterns; lethargy; disinterest in previously enjoyed activities; excessive irritability and restlessness; suicidal thoughts; and inability to concentrate. Depression often occurs in the presence of one or more other disorders. For example, depression is reported to be at a higher rate in people with chronic obstructive pulmonary disease (COPD) than in the general population. COPD is a disease in which the lungs are damaged, making it difficult to breathe. Symptoms most commonly include chronic coughing and shortness of breath. A primary cause of COPD is cigarette smoking. Following a prescribed treatment plan is important for managing COPD. Unfortunately, people with COPD often do not adhere to their treatment plans. Being depressed makes adherence even more difficult. This study will evaluate the effectiveness of problem-solving therapy integrated with adherence-enhanced procedures (PSA) in treating older people with major depression and COPD.

Participants in this open label study will be randomly assigned to one of two groups: PSA or PID-C. In PSA, a therapist will teach participants problem-solving strategies focusing on treatment adherence, depressive symptoms, and disability. Participants will learn behaviors and solutions to help cope with these problems. In PID-C, a therapist will teach participants to identify obstacles to treatment adherence and to discover ways to overcome them. The treatment sessions for both groups will be initiated at the inpatient Pulmonary Unit of Burke Rehabilitation Hospital and will continue in the participants' homes. All participants will receive two treatment sessions during hospitalization, eight weekly sessions following discharge, and four monthly sessions after that. While hospitalized at Burke, participants will also undergo an assessment interview for 1.5 hours and another interview for 20 minutes 2 weeks following the initial assessment. Interviews lasting 1.5 hours will also occur in the homes of the participants at Weeks 10, 14, and 26 after discharge from Burke. All assessments will focus on depression severity, level of general functioning, and COPD treatment adherence.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pulmonary Disease, Chronic Obstructive Depression

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Problem Solving-Rx Adherence (PSA)

Participants will receive problem-solving therapy integrated with adherence-enhanced procedures (PSA).

Group Type EXPERIMENTAL

Problem Solving-Rx Adherence (PSA)

Intervention Type BEHAVIORAL

In PSA, a therapist teaches the participant to identify problems related to depression, functioning, and treatment adherence; to generate multiple solutions; and to choose and implement one or more of those solutions.

PID-C

Participants will receive adherence-enhanced (PID-C) procedures, a treatment mobilizing patients to participate in their care.

Group Type ACTIVE_COMPARATOR

PID-C

Intervention Type BEHAVIORAL

In PID-C, a therapist identifies obstacles to treatment adherence and helps the participant overcome those obstacles.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Problem Solving-Rx Adherence (PSA)

In PSA, a therapist teaches the participant to identify problems related to depression, functioning, and treatment adherence; to generate multiple solutions; and to choose and implement one or more of those solutions.

Intervention Type BEHAVIORAL

PID-C

In PID-C, a therapist identifies obstacles to treatment adherence and helps the participant overcome those obstacles.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Meets American Thoracic Society criteria for COPD
* Meets DSM-IV criteria for unipolar major depression
* Scores greater than 19 on 24-item Hamilton Depression Rating Scale
* Fluency in English sufficient for comprehending the questionnaires of the study and for understanding the therapists

Exclusion Criteria

* Unable to give informed consent
* Experiencing suicidal thoughts
* History of or currently meets DSM-IV criteria for the following Axis I disorders: psychotic depression, psychotic disorder, bipolar disorder, dysthymic disorder, obsessive compulsive disorder, or current substance abuse
* Meets DSM-IV criteria for Axis II diagnosis of antisocial personality (by SCID-P and DSM-IV)
* Scores less than 24 on Mini-Mental State Exam (MMSE) or meets DSM-IV criteria for dementia
* Certain illnesses (e.g., untreated thyroid or adrenal disease, pancreatic cancer, lymphoma)
* Taking drugs known to cause depression (e.g., reserpine, alpha-methyl-dopa, steroids)
* Current involvement in psychotherapy
* Requires nursing home placement after discharge

Minimum Eligible Age

50 Years

Maximum Eligible Age

95 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No